First Trust Global Funds PLC A Dow Jones Internet UCITS ETF (GM) (FTGPF) News

AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)

AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa) PR Newswire NORTH CHICAGO, Ill., June 25, 2024 U.S. Food and Drug...

AbbVie Declares Quarterly Dividend

AbbVie Declares Quarterly Dividend PR Newswire NORTH CHICAGO, Ill., June 21, 2024 NORTH CHICAGO, Ill., June...

AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors

AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors PR Newswire NORTH...

U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease

U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio Across...

AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer

AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer PR Newswire NORTH CHICAGO, Ill., June 14, 2024 NORTH CHICAGO...

AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease

AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel...

BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients

BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients PR Newswire IRVINE...

AbbVie Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine (ELAHERE®) for High Folate Receptor-Alpha (FRα) Expressing Platinum-Sensitive Ovarian Cancer

AbbVie Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine...

SkinMedica® Celebrates 25 Years of Empowering Radiant Skin

SkinMedica® Celebrates 25 Years of Empowering Radiant Skin PR Newswire IRVINE, Calif., June 6, 2024 Allē...

AbbVie Launches First-of-its-Kind Contest to Empower People Living with Migraine in their Careers

AbbVie Launches First-of-its-Kind Contest to Empower People Living with Migraine in their Careers PR...

AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383

AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational...

RINVOQ® (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis

RINVOQ® (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile...

Refer Your Friends to Allē, the Loyalty Rewards Program by Allergan Aesthetics, and Earn $50

Refer Your Friends to Allē, the Loyalty Rewards Program by Allergan Aesthetics, and Earn $50 PR...

AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference PR Newswire NORTH CHICAGO...

Form SD - Specialized disclosure report